The Library
A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center
Tools
Chiang, J., Chan, A., Shih, V., Hee, Siew Wan, Tao, M. and Lim, S. T. (2010) A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center. International Journal of Hematology, 91 (5). pp. 826-830. doi:10.1007/s12185-010-0583-z ISSN 0925-5710 .
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://www.scopus.com/inward/record.url?eid=2-s2.0...
Abstract
Rituximab (Mabthera®) is currently approved for the treatment of multiple subtypes of CD20-expressing, B-cell, non-Hodgkin’s lymphoma. This study aimed to investigate whether rapid infusion of rituximab over 90 min is feasible without compromising patient’s safety, and to reduce resource utilization at a cancer center. This is a prospective and open label study. Lymphoma patients who have received one cycle of rituximab without experiencing grade 3 or 4 infusional reaction were eligible for the rapid infusion of rituximab. Rapid infusion rituximab is infused over 90 min, with 20% of the dose given over the first 30 min and the remaining 80% over 60 min. A total of 79 patients were recruited for this study with a total of 269 infusions administered. Sixty-nine patients (87.3%) received rituximab in combination with chemotherapy. Average number of rituximab infusions administered to patients was 3.4 cycles. Rapid rituximab infusion schedule was well tolerated without any grade 3/4 infusion-related adverse events observed. An average amount of time saved per patient was 10.2 h. Rapid infusion rituximab over 90 min was well tolerated by patients, and shortened infusions have resulted in substantial reduction of resource utilization.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Statistics and Epidemiology Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Journal or Publication Title: | International Journal of Hematology | ||||
Publisher: | Springer Japan KK | ||||
ISSN: | 0925-5710 | ||||
Official Date: | 2010 | ||||
Dates: |
|
||||
Volume: | 91 | ||||
Number: | 5 | ||||
Page Range: | pp. 826-830 | ||||
DOI: | 10.1007/s12185-010-0583-z | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Reuse Statement (publisher, data, author rights): | Cited By :10 Export Date: 5 March 2015 | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |